REGULATED PRESS RELEASE published on 08/01/2025 at 07:00, 10 months 20 days ago AXA : Rapport Financier Semestriel - 30 juin 2025
REGULATED PRESS RELEASE published on 07/31/2025 at 17:57, 10 months 20 days ago AXA : share buyback transactions
REGULATED PRESS RELEASE published on 07/31/2025 at 17:57, 10 months 20 days ago AXA : rachat d’actions
REGULATED PRESS RELEASE published on 07/24/2025 at 17:49, 10 months 27 days ago AXA: share buyback transactions
REGULATED PRESS RELEASE published on 07/24/2025 at 17:49, 10 months 27 days ago AXA: rachat d'actions
REGULATED PRESS RELEASE published on 07/17/2025 at 17:44, 11 months 3 days ago AXA: share buyback transactions
BRIEF published on 07/09/2025 at 18:05, 11 months 11 days ago AXA : Détails sur le capital et les droits de vote au 30 juin 2025 Euronext Paris Droits De Vote Franchissement De Seuil Capital Social AXA
BRIEF published on 07/09/2025 at 18:05, 11 months 11 days ago AXA Announces Updated Share Capital and Voting Rights Information Share Capital Voting Rights AXA Financial Regulation Disclosure Requirements
REGULATED PRESS RELEASE published on 07/09/2025 at 18:00, 11 months 11 days ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/06/2025 AXA communique le nombre total d'actions et de droits de vote au 30 juin 2025, conformément à la réglementation financière en vigueur Déclaration Droits De Vote Capital Social AXA Règlement Financier
REGULATED PRESS RELEASE published on 07/09/2025 at 18:00, 11 months 11 days ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/06/2025 AXA, a French public company, discloses information on voting rights and shares, in compliance with regulatory requirements Share Capital Voting Rights French Company AXA Regulatory Disclosure
Published on 06/20/2026 at 01:00, 1 day 12 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 13 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 8 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 12 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 12 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 15 hours 56 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 7 hours ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 17 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 17 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 18 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 17 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 17 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 17 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 17 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026